Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Combining a diabetes drug with a cancer drug not only kills aggressive bladder cancer cells in mice, but also turns remaining malignant cells into a more benign state.
Lewis Silverman, the new director of pediatric hematology, oncology, and stem cell transplantation, is working to minimize the aftereffects of treatment to ensure the highest quality cure possible.
A mutation that leads to relapse in many leukemia patients also causes a weakness that could be exploited to kill the cancer cells, Columbia researchers have reported.
A new study shows how stress accelerates pancreatic cancer development. Beta blockers, which block stress hormones, may increase survival for patients with the disease.
The fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive and increasing the amount of fuel available for rampant cell growth.
Cancer researchers at Columbia have discovered three genes that undermine the DNA repair process and promote tumor formation in cells with BRCA mutations.
Using electron microscopy, CUIMC biologists have captured the first detailed images of a calcium membrane pore in action, revealing a potential target for treating cancer.
An individual’s own genes play a role in the response to immunotherapy drugs, researchers in the Herbert Irving Comprehensive Cancer Center have found.
A CUMC-led study finds that acupuncture can reduce the joint pain caused by aromatase inhibitors, a drug taken by two-thirds of all breast cancer patients.
Columbia University and NYP announced today that Florence Irving and her late husband, Herbert Irving, have given $700 million to the two institutions to dramatically advance research and clinical programs for the treatment of cancer.